PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.62%
Revenue growth of 5.62% while QRVO is flat. Bruce Berkowitz would check if a small edge can widen further.
14.26%
Gross profit growth of 14.26% while QRVO is zero. Bruce Berkowitz would see if minimal improvements could expand further.
51.57%
EBIT growth of 51.57% while QRVO is zero. Bruce Berkowitz would see if small gains can be scaled further.
129.37%
Operating income growth of 129.37% while QRVO is zero. Bruce Berkowitz would see if this modest edge can become significant.
82.32%
Net income growth of 82.32% while QRVO is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
84.37%
EPS growth of 84.37% while QRVO is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
81.25%
Diluted EPS growth of 81.25% while QRVO is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
-0.36%
Share reduction while QRVO is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.53%
Reduced diluted shares while QRVO is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
33.67%
Dividend growth of 33.67% while QRVO is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
87.22%
OCF growth of 87.22% while QRVO is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
109.06%
FCF growth of 109.06% while QRVO is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
104.15%
10Y CAGR of 104.15% while QRVO is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
8.82%
5Y CAGR of 8.82% while QRVO is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
-4.55%
Negative 3Y CAGR while QRVO stands at 0.00%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
179.43%
OCF/share CAGR of 179.43% while QRVO is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
55.41%
OCF/share CAGR of 55.41% while QRVO is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
31.35%
3Y OCF/share CAGR of 31.35% while QRVO is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
754.81%
10Y net income/share CAGR of 754.81% while QRVO is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
34.33%
Net income/share CAGR of 34.33% while QRVO is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
-6.00%
Negative 3Y CAGR while QRVO is 0.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
58.52%
Equity/share CAGR of 58.52% while QRVO is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
32.67%
Equity/share CAGR of 32.67% while QRVO is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
24.26%
Equity/share CAGR of 24.26% while QRVO is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
1208.79%
Dividend/share CAGR of 1208.79% while QRVO is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
180.15%
Dividend/share CAGR of 180.15% while QRVO is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
130.21%
3Y dividend/share CAGR of 130.21% while QRVO is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
11.85%
AR growth of 11.85% while QRVO is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
1.18%
Inventory growth of 1.18% while QRVO is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
-1.54%
Negative asset growth while QRVO invests at 0.00%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
1.43%
BV/share growth of 1.43% while QRVO is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
-9.11%
We’re deleveraging while QRVO stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-7.16%
Our R&D shrinks while QRVO invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
2.61%
SG&A growth of 2.61% while QRVO is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.